Citations

Clear

390 citation(s) found for "Loftus, E".

P479 Analysis of haematological changes in tofacitinib-treated patients with ulcerative colitis across Phase 3 induction and maintenance studies
Lichtenstein, Gary R. , Soonasra, Arif, Nduaka, Chudi, Wang, L, Lawendy, Nervin, Chan, Geoffrey , Moore, Gregory , Kwok, Kenneth , Su, C, Loftus, Edward V.

Mayo Clinic

Journal of Crohn's and Colitis | January 25, 2019 | Volume: 13 | Issue: Supplement_1 | Pages: S351-S352

10.1093/ecco-jcc/jjy222.603 Get It

P313 Impact of upadacitinib on the general clinical condition of patients with Crohn’s disease (CD): data from the randomised CELEST study
Pugatch, David, Goteti, S, Lacerda, Ana P. , Loftus, Edward V. , Rubin, David T. , Panés, Julián , Zhou, Wen , Travis, Simon

Mayo Clinic

Journal of Crohn's and Colitis | January 25, 2019 | Volume: 13 | Issue: Supplement_1 | Pages: S257-S257

10.1093/ecco-jcc/jjy222.437 Get It

P283 Bowel urgency in patients with moderate to severe ulcerative colitis: prevalence and correlation with clinical outcomes, biomarker levels, and health-related quality of life from U-ACHIEVE, a Phase 2b study of upadacitinib
Louis, Édouard , Reinisch, Walter , Cataldi, Fabio, Lee, W-J, Ghosh, Subrata , Louis, Edouard , Loftus, Edward V. , Reinisch, Walter , Zhou, Wen , Lee, W-J, Panés, Julián

Mayo Clinic

Journal of Crohn's and Colitis | January 25, 2019 | Volume: 13 | Issue: Supplement_1 | Pages: S240-S241

10.1093/ecco-jcc/jjy222.407 Get It

Response to Chamberlin and Borody
Lichtenstein, Gary R. , Loftus, Edward V. , Isaacs, Kim L. , Loftus, Edward V , Regueiro, Miguel , Sands, Bruce E

Mayo Clinic

American Journal of Gastroenterology | January 19, 2019 | Volume: 114 | Issue: 1 | Pages: 171-174

10.14309/ajg.0000000000000077 | PMID 30633034 Get It

RDNA-06. A NOVEL ROLE OF SGEF IN MEDIATING GBM CELL SURVIVAL BY MODULATING THE DNA DAMAGE REPAIR MECHANISM
Tuncali, Serdar, Sereduk, Christopher, Ensign, Shannon P. Fortin , Kloss, Jean , Loftus, Joseph C. , Ensign, Shannon P. Fortin , Sereduk, Chris , Sarkaria, Jann N. , Tran, Nhan L.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi222-vi223

10.1093/neuonc/noy148.922 Get It

ANGI-02. A CRITICAL ROLE FOR LARG IN RhoC MEDIATED GLIOBLASTOMA CELL INVASION
Dong, Zhiwan , Ensign, Shannon P. Fortin , Sabit, Hemragul, Ruggieri, Rosamaria, Symons, Marc , Loftus, Joseph C. , Ensign, Shannon P. Fortin , Ding, Zonghui , Yang, Yuping , Nakada, Mitsutoshi , Tran, Nhan L.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi28-vi28

10.1093/neuonc/noy148.104 Get It

Update on the Natural Course of Fistulizing Perianal Crohn’s Disease in a Population-Based Cohort
Park, Sang Hyoung , Harmsen, William S. , Tremaine, William J., Faubion, William A. , Loftus, Edward V. , Aniwan, Satimai , Loftus, Edward V , Lightner, Amy L.

Mayo Clinic

Inflammatory Bowel Diseases | October 19, 2018 | Volume: 25 | Issue: 6 | Pages: 1054-1060

10.1093/ibd/izy329 | PMID 30346531 Get It

Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection
Solanky, Dipesh , Pardi, Darrell S. , Loftus, Edward V. , Khanna, Sahil , Loftus, Edward V

Mayo Clinic

Inflammatory Bowel Diseases | September 26, 2018 | Volume: 25 | Issue: 3 | Pages: 610-619

10.1093/ibd/izy291 | PMID 30260451 Get It

Abstract Background Inflammatory bowel disease (IBD) is an independent risk factor for Clostridium difficile infection (CDI), and CDI often precipitates IBD exacerbation. Because CDI cannot be distinguished clinically from an IBD exacerbation, management is difficult. We aimed to assess factors associated with adverse outcomes in IBD with CDI, including the role of escalating or de-escalating IBD therapy and CDI treatment. Methods Records for patients with IBD and CDI from 2008 to 2013 were abstracted for variables including IBD severity before CDI diagnosis, CDI management, subsequent IBD exacerbation, CDI recurrence, and colon surgery. Colon surgery was defined as resection of any colonic segment within 1 year after CDI diagnosis. Results We included 137 IBD patients (median age, 46 years; 55% women): 70 with ulcerative colitis (51%), 63 with Crohn’s disease (46%), and 4 with indeterminate colitis (3%). Overall, 70% of CDIs were mild-moderate, 14% were severe, and 15% were severe-complicated. Clostridium difficile infection treatment choice did not vary by infection severity (P = 0.27). Corticosteroid escalation (odds ratio [OR], 5.94; 95% confidence interval [CI], 2.03–17.44) was a positive predictor of colon surgery within 1 year after CDI; older age (OR, 0.09; 95% CI, 0.01–0.44) was a negative predictor. Modifying the corticosteroid regimen did not affect CDI recurrence or risk of future IBD exacerbation. Adverse outcomes did not differ with CDI antibiotic regimens or biologic or immunomodulator regimen modification. Conclusions Corticosteroid escalation for IBD during CDI was associated with higher risk of colon surgery. Type of CDI treatment did not influence IBD outcomes. Prospective studies are needed to further elucidate optimal management in this high-risk population.
Anti-Tumour Necrosis Factor Therapy for Inflammatory Bowel Diseases Do Not Impact Serious Infections after Arthroplasty
Gregory, Martin , Stwalley, Dustin , Hippensteel, K. J. , Loftus, Edward V. , Ciorba, Matthew A. , Deepak, Parakkal , Loftus, Edward V , Deepak, Parakkal , McKinnon, Andrew, Olsen, Margaret A A

Mayo Clinic

Journal of Crohn's and Colitis | September 22, 2018 | Volume: 13 | Issue: 2 | Pages: 182-188

10.1093/ecco-jcc/jjy148 | PMID 30256926 Get It

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus
Steinhart, A. Hillary , Bressler, Brian , Khanna, Reena , Afif, Waqqas , Bernstein, Çharles N. , Bitton, Alain , Borgaonkar, Mark , Chauhan, Usha, Halloran, Brendan P. , Jones, Jennifer , Kennedy, Erin , Meddings, Jonathan B., Plamondon, Sophie , Rosenfeld, Greg , Seow, Cynthia H. , Williams, Chadwick, Panaccione, Remo , Targownik, Laura E. , Marshall, John K. , Bernstein, Charles Noah , Leontiadis, Grigorios I. , Loftus, Edward V. , Moayyedi, Paul , Murthy, Sanjay K. , Schwartz, David A.

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | September 13, 2018 | Volume: 1 | Issue: 4 | Pages: 141-154

10.1093/jcag/gwy047 | PMID 31799497 Get It